Matrix Pharmaceutical Overview
- Year Founded
-
1985
- Status
-
Acquired/Merged
- Employees
-
106
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$62M
Matrix Pharmaceutical General Information
Description
Manufacturer of novel drug product candidates for cancer. The company develops novel local and systemic cancer treatments that may improve or extend the lives of people living with cancer.
Contact Information
Website
www.matrixpharma.comCorporate Office
- 34700 Campus Drive
- Fremont, CA 94555
- United States
Corporate Office
- 34700 Campus Drive
- Fremont, CA 94555
- United States
Matrix Pharmaceutical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Merger/Acquisition | 01-Jan-2002 | $62M | Completed | Product Development | ||
| 6. PIPE | 01-Jul-2000 | Completed | Generating Revenue | |||
| 5. PIPE | 01-Aug-1995 | Completed | Generating Revenue | |||
| 4. PIPE | 01-Aug-1994 | Completed | Generating Revenue | |||
| 3. IPO | 28-Jan-1992 | Completed | Product Development | |||
| 2. Early Stage VC | 01-Jan-1990 | $8M | $13.4M | Completed | Product Development | |
| 1. Early Stage VC | $5.4M | $5.4M | Completed |
Matrix Pharmaceutical Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Matrix Pharmaceutical Patents
Matrix Pharmaceutical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2011120040-A2 | Thrombin inhibiting compositions | Inactive | 26-Mar-2010 | ||
| WO-2011120040-A3 | Thrombin inhibiting compositions | Inactive | 26-Mar-2010 | ||
| WO-2002092055-A1 | Oxidized collagen formulations for use with non-compatible pharmaceutical agents | Inactive | 15-May-2001 | ||
| US-20030109487-A1 | Deoxy-2'-(fluoromethylene)cytidine; and (b) administering to the patient an effective amount of a platinate; wherein the amounts of (e)-2'-deoxy-2'- (fluoromethylene)cytidine and platinate are selected to provide cellular proliferation | Active | 02-Nov-2000 | ||
| CA-2326004-A1 | Methods for treating cellular proliferative disorders | Inactive | 02-Nov-2000 | A61K31/70 |
Matrix Pharmaceutical Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Matrix Pharmaceutical Former Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Canaan Partners | Venture Capital | Minority |
Matrix Pharmaceutical FAQs
-
When was Matrix Pharmaceutical founded?
Matrix Pharmaceutical was founded in 1985.
-
Where is Matrix Pharmaceutical headquartered?
Matrix Pharmaceutical is headquartered in Fremont, CA.
-
What is the size of Matrix Pharmaceutical?
Matrix Pharmaceutical has 106 total employees.
-
What industry is Matrix Pharmaceutical in?
Matrix Pharmaceutical’s primary industry is Pharmaceuticals.
-
Is Matrix Pharmaceutical a private or public company?
Matrix Pharmaceutical is a Private company.
-
What is the current valuation of Matrix Pharmaceutical?
The current valuation of Matrix Pharmaceutical is .
-
What is Matrix Pharmaceutical’s current revenue?
The current revenue for Matrix Pharmaceutical is .
-
How much funding has Matrix Pharmaceutical raised over time?
Matrix Pharmaceutical has raised $125M.
-
Who are Matrix Pharmaceutical’s investors?
Canaan Partners has invested in Matrix Pharmaceutical.
-
When was Matrix Pharmaceutical acquired?
Matrix Pharmaceutical was acquired on 01-Jan-2002.
-
Who acquired Matrix Pharmaceutical?
Matrix Pharmaceutical was acquired by Chiron (Biotechnology).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
